Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Dyslipidemia

Free Subscription Articles published in Metabolism Retrieve available abstracts of 13 articles: HTML format

Single Articles

February 2026
1. ZHOU Y, Dai Y, Qin M, Li Y, et al
   FAM83A acts as an amplifier for lipogenic signaling to facilitate the pathogenesis of metabolic dysfunction-associated steatohepatitis.
   Metabolism. 2026;175:156462.
   PubMed     Abstract available
   
   
   
2. MARKAKIS K, Abadi LF, Kombe AK, Christodoulides M, et al
   HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?
   Metabolism. 2026;175:156432.
   PubMed     Abstract available
   
   
   October 2025
3. LI L, Wang Y, Du Z, Yu H, et al
   Hepatic aconitase 1 redirects citrate flux to suppress lipogenesis and ameliorate hypercholesterolemia.
   Metabolism. 2025 Oct 7:156417. doi: 10.1016/j.metabol.2025.156417.
   PubMed     Abstract available
   
   
   July 2025
4. WANG Y, Wu Y, Jiang H, Li S, et al
   L-Kynurenine activates the AHR-PCSK9 pathway to mediate the lipid metabolic and ovarian dysfunction in polycystic ovary syndrome.
   Metabolism. 2025;168:156238.
   PubMed     Abstract available
   
   
   March 2025
5. DE MOURA DE SOUZA M, Mendes BX, Defante MLR, de Athayde de Hollanda Morais BA, et al
   Apolipoprotein C-III inhibitors for the treatment of hypertriglyceridemia: A meta-analysis of randomized controlled trials.
   Metabolism. 2025 Mar 10:156187. doi: 10.1016/j.metabol.2025.156187.
   PubMed     Abstract available
   
   
   November 2024
6. CONGUR I, Mingrone G, Guan K
   Targeting endoplasmic reticulum stress as a potential therapeutic strategy for diabetic cardiomyopathy.
   Metabolism. 2024 Nov 6:156062. doi: 10.1016/j.metabol.2024.156062.
   PubMed     Abstract available
   
   
   September 2024
7. JEONG JH, Kim YG, Han KD, Roh SY, et al
   Association of fatty liver index with sudden cardiac arrest in young adults.
   Metabolism. 2024;158:155981.
   PubMed     Abstract available
   
   
   
8. DANPANICHKUL P, Suparan K, Dutta P, Kaeosri C, et al
   Disparities in metabolic dysfunction-associated steatotic liver disease and cardiometabolic conditions in low and lower middle-income countries: a systematic analysis from the global burden of disease study 2019.
   Metabolism. 2024;158:155958.
   PubMed     Abstract available
   
   
   July 2024
9. HAGVE M, Pereira SL, Walker DK, Engelen MPKJ, et al
   Statin treatment reduces leucine turnover, but does not affect endogenous production of beta-hydroxy-beta-methylbutyrate (HMB).
   Metabolism. 2024;156:155920.
   PubMed     Abstract available
   
   
   June 2024
10. EZHILARASAN D
    Deciphering the molecular pathways of saroglitazar: A dual PPAR alpha/gamma agonist for managing metabolic NAFLD.
    Metabolism. 2024;155:155912.
    PubMed     Abstract available
    
    
    April 2024
11. ZELJKOVIC A, Vekic J, Stefanovic A
    Obesity and dyslipidemia in early life: Impact on cardiometabolic risk.
    Metabolism. 2024;156:155919.
    PubMed     Abstract available
    
    
    November 2023
12. ZUO F, Wang Y, Xu X, Ding R, et al
    CCDC92 deficiency ameliorates podocyte lipotoxicity in diabetic kidney disease.
    Metabolism. 2023 Nov 10:155724. doi: 10.1016/j.metabol.2023.155724.
    PubMed     Abstract available
    
    
    July 2023
13. WANG YD, Wu LL, Mai YN, Wang K, et al
    miR-32-5p induces hepatic steatosis and hyperlipidemia by triggering de novo lipogenesis.
    Metabolism. 2023 Jul 12:155660. doi: 10.1016/j.metabol.2023.155660.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dyslipidemia is free of charge.